- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin glargine 300 U/mL
Total 1022 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
SanofiCompletedDiabetes Mellitus, Type 2Turkey
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompleted
-
SanofiCompleted
-
Eli Lilly and CompanyCompleted
-
Ruhr University of BochumCompleted
-
SanofiCompletedDiabetes Mellitus Type 2
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Diabetes Care CenterUnknownDiabetes Mellitus Type 1United States
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
SanofiCompletedDiabetes Mellitus, Type 2Austria, United Arab Emirates, Spain, Romania, Colombia, Korea, Republic of, Brazil, Greece, Italy, China, Denmark, India, Kuwait, Mexico, Taiwan, Turkey
-
Universidad Nacional de AsunciónCompletedHyperglycemia | DiabetesParaguay
-
Mannkind CorporationTerminatedDiabetes, Type 1United States, Brazil
-
University of WashingtonNational Institute on Aging (NIA)CompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Chronic Kidney DiseaseMexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
-
SanofiCompletedDiabetes Mellitus, Type 1Belarus
-
SanofiCompletedInsulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompleted
-
Inova Health Care ServicesTerminated
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
Wake Forest University Health SciencesActive, not recruitingCognitive Impairment | Mild Cognitive ImpairmentUnited States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
University of Colorado, DenverSanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Slovakia, United Kingdom, France, Argentina, South Africa, Germany, Slovenia, Netherlands, Romania, North Macedonia, Mexico, Puerto Rico
-
University of AlbertaSanofiCompleted
-
University of MinnesotaSanofi; Moran, Antoinette, M.D.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersGermany
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompletedDiabetes Mellitus, Type 2Jordan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
SanofiCompleted
-
GeropharmCompletedClamp StudyRussian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada